Value in Health, June 2019Jane F. Barlow, Mo Yang, and J. Russell Teagarden Access to new gene therapies may be impacted by payer ability to absorb the cost of coverage. … Read More
American College of Rheumatology joins NEWDIGS LEAPS Project
Initiative to design a systemwide “learning engine” for rheumatoid arthritis in Massachusetts The American College of Rheumatology (ACR), an international medical association that serves more than 8,500 members of the … Read More
Massachusetts Pilot Disease Selection
Rheumatoid Arthritis (RA) chosen as target for LEAPS Massachusetts (MA) Pilot (RAMA) to demonstrate the feasibility and impact of a sustainable and patient-centered healthcare learning ecosystem to optimize care regimens … Read More
Pediatric Gene Therapy Launches
Gene therapy cures for hereditary genetic conditions are likely to reach the United States market in the coming decades. Several disease areas with potential cures are orphan conditions, which affect … Read More
Patient & Caregiver Themes Survey
Patients and caregivers are key stakeholders in the development of system-wide, implementable precision financing models for durable and curative therapies. Patient and caregiver challenges are generally assumed to be primarily … Read More
Address: From Bigger Data to Smarter Evidence
On Tuesday, February 26th, Dr Gigi Hirsch, Executive Director of MIT NEWDIGS, gave a presentation for the Harvard-MIT Center for Regulatory Science to a gathering of local academic, clinical, and industry leaders … Read More
Preparing Patients and the Health System for Curative Therapies in the Pipeline
American Journal of Managed Care Curative therapies represent a conundrum for healthcare. On the one hand, there is the ability to cure patients of potentially life-threatening diseases or diseases that … Read More
MIT Releases New Policy and Practice Suggestions to Make Cures Accessible and Sustainable
Innovative Therapies Will Require Innovations in Financing and Regulations WASHINGTON, DC, February 12—Today, the MIT-based Financing and Reimbursement of Cures in the US (FoCUS) consortium released a series of large-scale … Read More
“Dynamic Dossier in the Cloud” to Transform Data Sharing, Starting with Federal Regulators
New platform will redefine biopharmaceutical data sharingMIT NEWDIGS and the Harvard-MIT Center for Regulatory Science announced the Dynamic Dossier in the Cloud today, a radical new platform that promises to … Read More